Maintenance Phase Ozempic
99 snips
Oct 10, 2023 
Mike and Aubrey discuss the sensational claims of Ozempic, the potential end to the Obesity Epidemic. They delve into the origins and function of the drug, as well as conflicting views on pharmaceutical companies and weight loss treatments. They explore the efficacy and side effects of semagitide trials, and the frustrating experiences of fat individuals seeking medical advice. The podcast also examines Novo Nordisk's marketing practices and critiques the reporting of influencer partnerships and body positivity.
AI Snips
Chapters
Transcript
Episode notes
Ozempic's Origin
- Ozempic's origins trace back to 1984 with Dr. Daniel Drucker's discovery of GLP-1.
- Research on Gila monsters, known for appetite control, led to Ozempic's development.
Ozempic's Mechanism
- Ozempic mimics GLP-1, a hormone released after eating, promoting fullness.
- It slows digestion and may improve insulin production.
Ozempic and Diabetes
- Clinical trials show Ozempic significantly lowers A1C levels in diabetic patients.
- This reduces risks of blindness, kidney failure, nerve damage, and heart problems.